Transcription News and Research

RSS
Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

5 Apr 2022
HIV drug stops disease progression in 25% of patients with fourth-line metastatic colorectal cancer

HIV drug stops disease progression in 25% of patients with fourth-line metastatic colorectal cancer

5 Apr 2022
Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

5 Apr 2022
Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

Study investigates the local-mucosal susceptibility and innate immune response to Omicron compared to other variants

5 Apr 2022
Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

5 Apr 2022
Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

Recombinant fragment of the lectin-binding region of Gal-3BP stimulates the expression of IL-6 in SARS-CoV-2 sensitive cells

5 Apr 2022
“MixOmicron” SARS-CoV-2 recombinant evades variant screening

“MixOmicron” SARS-CoV-2 recombinant evades variant screening

5 Apr 2022
Study generates a picture of the myocardial transcriptional landscape of COVID-19

Study generates a picture of the myocardial transcriptional landscape of COVID-19

5 Apr 2022
Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

5 Apr 2022
Study on the efficacy of a BNT162b2 booster dose in the elderly

Study on the efficacy of a BNT162b2 booster dose in the elderly

5 Apr 2022
Air surveillance of SARS-CoV-2 and other respiratory pathogens

Air surveillance of SARS-CoV-2 and other respiratory pathogens

4 Apr 2022
SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

4 Apr 2022
Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

Study suggests severe neuroinvasion by SARS-CoV-2 in individuals with alcohol use disorder

4 Apr 2022
COVID-19 study proves ivermectin ineffective

COVID-19 study proves ivermectin ineffective

4 Apr 2022
How well does the BNT162b2 vaccine protect children and teens against Omicron?

How well does the BNT162b2 vaccine protect children and teens against Omicron?

4 Apr 2022
An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

Study investigates messenger ribonucleic acid-based SARS-CoV-2 vaccine efficacy against SARS-CoV-2 Omicron in Denmark

1 Apr 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
Study identifies implications of long-COVID on long term physical and mental health

Study identifies implications of long-COVID on long term physical and mental health

31 Mar 2022
Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

Study estimates the comparative abundance of SARS-CoV-2 variants via wastewater monitoring

31 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback